Main menu button

News

Hanza: Vorteile eines Fertigungsclusters
08 Mrz 2022
Hanza: Vorteile eines Fertigungsclusters
Equity Research
Mrkt BUZZ GHP Specialty Care: Cash offer at SEK 35 per share
07 Mrz 2022
Mrkt BUZZ GHP Specialty Care: Cash offer at SEK 35 per share
Equity Research GHP Specialty Care
Mrkt BUZZ Medclair Invest: Explosive growth to be expected in 2022
03 Mrz 2022
Mrkt BUZZ Medclair Invest: Explosive growth to be expected in 2022
Equity Research
Research update Risk Intelligence, Q4 2021: Initiatives seem to be bearing fruit
28 Feb 2022
Research update Risk Intelligence, Q4 2021: Initiatives seem to be bearing fruit
Equity Research Risk Intelligence
Research Update Raytelligence, Q4 2021: US gains importance after strategy shift
28 Feb 2022
Research Update Raytelligence, Q4 2021: US gains importance after strategy shift
Equity Research
Research Update H&D Wireless, Q4 2021: Slightly lower revenues, but also breakthroughs
28 Feb 2022
Research Update H&D Wireless, Q4 2021: Slightly lower revenues, but also breakthroughs
Equity Research
Research Update Spotlight Group, Q4 2021: Increasing short-term risk
28 Feb 2022
Research Update Spotlight Group, Q4 2021: Increasing short-term risk
Equity Research Spotlight Group
First Impression, Nischer Properties Q4 2021: Impairment of property value dragged down results
28 Feb 2022
First Impression, Nischer Properties Q4 2021: Impairment of property value dragged down results
Equity Research Nischer Properties
First impression, Midsummer q4 2021: Strong momentum in both business areas
25 Feb 2022
First impression, Midsummer q4 2021: Strong momentum in both business areas
Equity Research Midsummer
First impression, Raytelligence Q4 2021: Offensive sales target for 2022 maintained
25 Feb 2022
First impression, Raytelligence Q4 2021: Offensive sales target for 2022 maintained
Equity Research
First impression, H&D Wireless Q4/2021: Weaker results than expected - but revenues are expected to increase in 2022
25 Feb 2022
First impression, H&D Wireless Q4/2021: Weaker results than expected - but revenues are expected to increase in 2022
Equity Research
Research Update SBB i Norden, Q4 2021: Continued capital gains in the properties
25 Feb 2022
Research Update SBB i Norden, Q4 2021: Continued capital gains in the properties
Equity Research SBB i Norden
First Impression Pharmiva, Q4, 2021: Progress in Sweden
24 Feb 2022
First Impression Pharmiva, Q4, 2021: Progress in Sweden
Equity Research
First impressions Risk Intelligence, Q4 2021: In line with expectations and confirmed outlook for the case
23 Feb 2022
First impressions Risk Intelligence, Q4 2021: In line with expectations and confirmed outlook for the case
Equity Research Risk Intelligence
First impression, SBB i Norden Q4/2021: SEK 2.2 billion in profit from associated companies and higher NRV
23 Feb 2022
First impression, SBB i Norden Q4/2021: SEK 2.2 billion in profit from associated companies and higher NRV
Equity Research SBB i Norden
Research Update Ecoclime, Q4 2021: Increased revenues and improved gross margins
18 Feb 2022
Research Update Ecoclime, Q4 2021: Increased revenues and improved gross margins
Equity Research
First Impression Ecoclime, Q4 2021: Better turnover and higher gross margin
17 Feb 2022
First Impression Ecoclime, Q4 2021: Better turnover and higher gross margin
Equity Research
First impression Spotlight Group, Q4 2021: In line with high expectations
16 Feb 2022
First impression Spotlight Group, Q4 2021: In line with high expectations
Equity Research Spotlight Group
Preview SBB i Norden: Value added gains on the properties
10 Feb 2022
Preview SBB i Norden: Value added gains on the properties
Equity Research SBB i Norden
Mrkt BUZZ Pharmiva: Promising Start for Vernivia
03 Feb 2022
Mrkt BUZZ Pharmiva: Promising Start for Vernivia
Equity Research